Literature DB >> 15927886

Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14).

Nadja Leukert1, Clemens Sorg, Johannes Roth.   

Abstract

S100 proteins form characteristic homo- and/or heterodimers that play a role in calcium-mediated signaling. We characterized the formation of the human S100A8/S100A9 heterodimer using the yeast two-hybrid system. Employing site-directed mutagenesis we found that distinct hydrophobic amino acids of helix I/I' are located at a crucial site of the S100A8/S100A9 dimer interface, whereas conserved residues within helix IV/IV' are not important for heterodimerization. Furthermore, amino acids Y16 and F68 prevent homodimerization of human S100A8. These data demonstrate for the first time the functional relevance of distinct hydrophobic amino acids for human S100A8/S100A9 complex formation in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927886     DOI: 10.1515/BC.2005.051

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  20 in total

1.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

Review 2.  Transition Metal Sequestration by the Host-Defense Protein Calprotectin.

Authors:  Emily M Zygiel; Elizabeth M Nolan
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

Review 3.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

4.  High-affinity manganese coordination by human calprotectin is calcium-dependent and requires the histidine-rich site formed at the dimer interface.

Authors:  Joshua A Hayden; Megan Brunjes Brophy; Lisa S Cunden; Elizabeth M Nolan
Journal:  J Am Chem Soc       Date:  2012-12-31       Impact factor: 15.419

5.  Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.

Authors:  Prokopios P Argyris; Zachary Slama; Chris Malz; Ioannis G Koutlas; Betty Pakzad; Ketan Patel; Deepak Kademani; Ali Khammanivong; Mark C Herzberg
Journal:  Oral Oncol       Date:  2019-06-04       Impact factor: 5.337

Review 6.  Calprotectin and the Initiation and Progression of Head and Neck Cancer.

Authors:  P P Argyris; Z M Slama; K F Ross; A Khammanivong; M C Herzberg
Journal:  J Dent Res       Date:  2018-02-14       Impact factor: 6.116

Review 7.  Review of S100A9 biology and its role in cancer.

Authors:  Joseph Markowitz; William E Carson
Journal:  Biochim Biophys Acta       Date:  2012-11-01

8.  Calprotectin S100A9 calcium-binding loops I and II are essential for keratinocyte resistance to bacterial invasion.

Authors:  Chantrakorn Champaiboon; Kaia J Sappington; Brian D Guenther; Karen F Ross; Mark C Herzberg
Journal:  J Biol Chem       Date:  2009-01-03       Impact factor: 5.157

Review 9.  Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer.

Authors:  Fatemeh Shabani; Alireza Farasat; Majid Mahdavi; Nematollah Gheibi
Journal:  Inflamm Res       Date:  2018-08-06       Impact factor: 4.575

10.  Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation.

Authors:  Thomas Vogl; Athanasios Stratis; Viktor Wixler; Tom Völler; Sumita Thurainayagam; Selina K Jorch; Stefanie Zenker; Alena Dreiling; Deblina Chakraborty; Mareike Fröhling; Peter Paruzel; Corinna Wehmeyer; Sven Hermann; Olympia Papantonopoulou; Christiane Geyer; Karin Loser; Michael Schäfers; Stephan Ludwig; Monika Stoll; Tomas Leanderson; Joachim L Schultze; Simone König; Thomas Pap; Johannes Roth
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.